ProCE Banner Activity

Novel Therapies, Healthcare Transitions, and Disparities in Atopic Dermatitis Care

Clinical Thought

This expert commentary reviews strategies for incorporating novel therapies, addressing healthcare disparities, and transitions of care for patients with moderate to severe atopic dermatitis.


In Collaboration With Clinical Care Options, LLC

Released: September 16, 2022

Expiration: September 15, 2023

Begin Activity

Share

Faculty

Robert Sidbury

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Children’s Hospital
University of Washington School of Medicine
Seattle, Washington

Acknowledgement

This program is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Novartis Pharmaceuticals Corporation; and Sanofi and Regeneron Pharmaceuticals.

This activity is supported by educational grants from Sanofi and Regeneron Pharmaceuticals.

Target Audience

Dermatologists and APPs and nurses who practice in dermatology.

Disclosure

Robert Sidbury, MD, MPH: consultant/advisor/speaker: Beiersdorf, Leo, Lilly.

Format

ClinicalThought

Additional Information

Program Medium

This program has been made available online.